Peppy vs. Skye Peptides: a research login is not a consultation

Disclosure: Peppy Care publishes this comparison of its own service. Public information checked October 22, 2026; no firsthand product testing. Seller statements are attributed, not independently certified.

The Skye Peptides domain leads to a login page. The page describes research and development use, excludes human consumption, and identifies the business as a chemical supplier rather than a 503A pharmacy or 503B outsourcing facility. We did not enter a customer account or inspect a private catalog.

This limits the comparison in a useful way: public access rules can be described, but private inventory and checkout details cannot. The login screen should not be turned into a claim that the company has stopped operating. Nor should similarly named stores be assumed to be the same seller.

Many kinds of businesses require accounts. An account can manage access permissions, orders, or research declarations without creating a medical relationship. A username, password, or approval message does not identify a clinician responsible for diagnosing a condition or monitoring a treatment.

Before interpreting an onboarding flow as healthcare, ask what professional service the person receives. Is there a licensed prescriber who evaluates the medical history? Is a prescription required for the proposed medicine? Is the dispensing pharmacy identified? The FDA’s online-pharmacy guidance provides checks relevant to medicines; a research supplier’s account process answers a different question.

Peppy’s shipping policy describes a licensed provider reviewing a health intake. If a plan is approved, a prescription goes to a licensed compounding pharmacy. That does not guarantee a prescription, a particular peptide, or service eligibility in every state.

A useful intake should lead to a reasoned decision, including the possibility that a requested treatment is inappropriate. Ask what information the clinician needs and how unanswered questions are handled. Our guide to a first telehealth appointment can help organize symptoms, current medicines, and goals before a visit. That preparation has a different purpose from satisfying a supplier’s account requirements.

For a medical pathway, look past the interface to the actual prescriber, pharmacy, evidence, and follow-up arrangements. FDA explains that compounded drugs are not FDA-approved; the presence of a consultation does not erase that distinction. Ask about approved alternatives and why any proposed compounded preparation is necessary for your circumstances.

For Skye Peptides, this review is limited to the accessible research-use notice. For Peppy, the published process is a starting point that patients should confirm for their own care. Neither an attractive account portal nor a research-access restriction substitutes for those concrete checks. The meaningful comparison is what happens professionally after information is submitted.